250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Life Science VC (Venture Capital) Funds in United Kingdom in September 2025

A list of 50 VC (Venture Capital) funds that invest in Life science startups based in United kingdom. We rank investors based on the number of investments they made in Life science companies from United kingdom. We update this investor list every month.

Top 50 Life Science VC (Venture Capital) Funds in United Kingdom in September 2025

Investor Life Science United Kingdom investments
Parkwalk Advisors 17
Oxford Science Enterprises 14
UK Innovation & Science Seed Fund 14
SOSV 13
Sofinnova Partners 8
Development Bank of Wales 8
GM&C Life Sciences Fund 7
Oxford Science Enterprises 7
Archangels 7
24 Haymarket 7
Syncona Partners LLP 7
Scottish Enterprise 6
Selvedge Venture 6
Newable Private Investing 6
IQ Capital 6
Angels in MedCity 6
Kindred Capital 6
Future Planet Capital 6
Scottish Investment Bank 6
Epidarex Capital 5
APEX Ventures 5
APEX Ventures 5
Deepbridge Capital 5
Verve Ventures 4
11.2 Capital 4
Angels 5K 4
Octopus Ventures 4
Techstart Ventures 4
AlbionVC 4
Cambridge Innovation Capital 4
IP Group 4
Playfair Capital 4
O2h Ventures 4
Mercia Fund Managers 4
Oxford Capital 4
Formic Ventures 4
Dementia Discovery Fund 4
SR One 4
Bioeconomy Capital 3
Fifty Years 3
Molten Ventures 3
Antler 3
Praetura Ventures 3
Maki.vc 3
Amadeus Capital Partners 3
Creator Fund 3
GV 3
Maven Capital Partners 3
Hoxton Ventures 3
Acequia Capital (AceCap) 3
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Parkwalk Advisors VC Fund · London, England, United Kingdom · 7 investments in the past 12 months
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Series A, Series B
  • United Kingdom, United States, Philippines
Portfolio highlights
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
  • Ceryx Medical — Ceryx Medical Ltd are the revolutionary business behind a unique bioelectronic technology that could change the way diseases such as heart failure are treated.
  • Enhanc3D Genomics — Enhanc3D Genomics is a spinout company from Babraham Institute.
Oxford Science Enterprises VC Fund · Oxford, Oxfordshire, United Kingdom · 3 investments in the past 12 months
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Seed, Series A, Series B
  • United Kingdom, United States, Finland
Portfolio highlights
  • FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
  • Neu Health — Neu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.
  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
UK Innovation & Science Seed Fund VC Fund · Harwell, Oxfordshire, United Kingdom · 11 investments in the past 12 months
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • Messium — Messium's technology makes use of proprietary machine learning models and hyperspectral satellite constellations.
  • Spaceflux — As satellites become increasingly vital, Spaceflux tackles the growing challenges of orbital congestion and debris that put them at risk. Thanks to our proprietary global network of optical sensors, we provide data-driven space situational awareness services from LEO to Cislunar.
  • Myosin Therapeutics — Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications targeting cellular motor proteins.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 18 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
  • One Biosciences — One Biosciences unlocks routine analysis of tumor heterogeneity through AI-powered single-cell technologies, transforming precision medicine.
  • Galvanize Therapeutics — Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitissymptoms, cardiac arrhythmias, and solid tumors.It was formed by Apple Tree Partners in 2022.
Development Bank of Wales VC Fund · Cardiff, Cardiff, United Kingdom · 12 investments in the past 12 months
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Debt Financing
  • United Kingdom, Australia, United States
Portfolio highlights
  • nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
  • Ceryx Medical — Ceryx Medical Ltd are the revolutionary business behind a unique bioelectronic technology that could change the way diseases such as heart failure are treated.
  • Lumin Solutions — Making care recording simpler, safer & child-focused for UK youth care providers. MyLifePlan helps you save time, ensure compliance & deliver outstanding care. Discover how!
GM&C Life Sciences Fund VC Fund · Alderley Edge, Cheshire, United Kingdom
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Italy, Germany
Portfolio highlights
  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Flynotes — Flynotes is a digital software platform helping dentists deliver personalised patient care
  • QV Bioelectronics — Manchester-based start-up QV Bioelectronics is developing innovative electrotherapy devices for the treatment of certain types of brain tumours.
Oxford Science Enterprises VC Fund · Oxford, Oxfordshire, United Kingdom · 3 investments in the past 12 months
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more
Investment focus
  • Health Care, Biotechnology, Software
  • Series A, Seed, Series B
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
  • Neu Health — Neu Health enables clinicians, care givers and patients to tackle this growing challenge with cutting-edge digital technologies designed to make the latest care accessible for all, improving outcomes today and accelerating future breakthroughs.
  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
Archangels VC Fund · Edinburgh, Edinburgh, City of, United Kingdom
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Funding Round, Seed, Series A
  • United Kingdom, United States
Portfolio highlights
  • CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
  • iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
24 Haymarket VC Fund · London, England, United Kingdom
24Haymarket is an investment network which included several highly-experienced private equity and venture capital investors, seasoned entrepreneurs, and senior operators. Investing up to £5 million in growth companies in the UK and Europe. They invested their own capital in direct alignment with entrepreneurs and actively support their growthagenda and join the board of the companies in which they invest. Since inception in 2011, 24Haymarket has invested in more than 50 high-growth businesses.
Show more
Investment focus
  • Health Care, Software, Information Technology
  • Funding Round, Seed, Series A
  • United Kingdom, United States
Portfolio highlights
  • CyberOwl — Helping maritime fleet operators gain visibility, cybersecurity and cyber compliance of shipboard systems with IMO 2021.
  • Optalitix — Optalitix's data driven products and expertise allow you to move your models to the cloud and improve underwriting efficiency.
  • onHand — The volunteering and climate impact platform for businesses and individuals. Help your local communities and have global impact.
Syncona Partners LLP VC Fund · London, England, United Kingdom · 3 investments in the past 12 months
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Seed
  • United Kingdom, United States, Switzerland
Portfolio highlights
  • Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
  • Purespring Therapeutics — Purespring Therapeutics is an AAV gene therapy company focused on the kidney globally.
  • Resolution Therapeutics — Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.
Scottish Enterprise VC Fund · Glasgow, Glasgow City, United Kingdom · 21 investments in the past 12 months
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Seed, Grant, Funding Round
  • United Kingdom, United States, Japan
Portfolio highlights
  • Swurf — The work surfing platform. Making it easy for venues to welcome a new community of remote workers.
  • Gigged.AI — Get AI-powered, real-time visibility over your tech team capabilities to power internal mobility. Fill skill gaps with ease using our on-demand talent network.
  • Bright Ascension — Bright Ascension offers mission ready software in space and on the ground. Our integrated software is perfect for any satellite mission.
Selvedge Venture VC Fund · London, England, United Kingdom
Selvedge Venture operates as a venture capital firm investing for impact in age-related medical conditions.
Show more
Investment focus
  • Health Care, Biotechnology, Life Science
  • Seed, Pre-Seed, Series A
  • United Kingdom, Singapore
Portfolio highlights
  • Mesh Bio — Mesh Bio is a digital health startup that is transforming chronic disease management through predictive analytics. Mesh Bio works with healthcare providers and stakeholders to provide innovative solutions that transform health screening and disease management. They translate clinical data and numbers into actionable insights that help patientsbetter manage their health, lifestyle and disease risks.
  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
Newable Private Investing VC Fund · London, England, United Kingdom
Newable: Helping over 20,000 businesses thrive annually with tailored financial products, advice, and flexible workspace solution
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States
Portfolio highlights
  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
IQ Capital VC Fund · Cambridge, Cambridgeshire, United Kingdom · 9 investments in the past 12 months
IQ Capital is a Cambridge & London-based VC firm that invests in ‘deep tech’ companies capable of dominating their respective markets on a global scale. Initial investments at Seed and Series A range from £0.5m to £10m, with capacity for follow-on investment up to £30m through the Growth Fund. The team has achieved over 30 exits including toApple, Huawei, Google and Oracle.
Show more
Investment focus
  • Software, Artificial Intelligence, Machine Learning
  • Seed, Series A, Funding Round
  • United Kingdom, United States, The Netherlands
Portfolio highlights
  • RevEng — The AI powered binary analysis platform for reverse engineering and malware analysis.
  • Nyobolt — Energy Storage and Power Management Solutions for High-Power Industries
  • Alpine Eagle — The Sentinel Counter-UAS System is an air-to-air sensor & interceptor network designed to detect, classify, and intercept unmanned aerial systems (UAS)
Angels in MedCity VC Fund · London, England, United Kingdom
Angels in MedCity is a partnership between MedCity, London Business Angels and Angels4LifeSciences. The programme aims to introduce new people to investing and investing in the healthcare/life sciences sector via investor workshops and introduce business angels to investment opportunities from highly-selected and trained companies.With aparticular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. The aim is to build investor understanding in the life sciences sector and support life sciences companies to gain funding to commercialise their ideas.Angels in MedCity has created a community of investors supported through a programme of investor workshops. Using case studies and tips from experienced investors in the field, the workshops explain how to identify and structure a good deal in the life sciences sector, as well as provide expert advice on tax breaks and legal issues.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Angel
  • United Kingdom, United States
Portfolio highlights
  • Atelerix — Discover Atelerix's hypothermic hydrogels for eco-friendly, reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples today.
  • Clustermarket — The intuitive lab management system for all academic research facilities and industrial laboratories that need to efficiently manage equipment bookings.
  • DynamX Medical — DynamX Medical has developed a reliable and inexpensive precancer screening system for rapid tissue biopsy analysis that can be operated point-of-care by nurses.
Kindred Capital VC Fund · London, England, United Kingdom · 9 investments in the past 12 months
A new model for Venture Capital where every founder we back becomes a co-owner of the fund
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Cakewalk — Cakewalk enables IT & Security teams to monitor all SaaS apps used by their employees, run compliant access flows, securely on- and offboard people, and be IT audit-ready.
  • Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
  • Sohar Health — Streamline patient intake and boost revenue with Sohar's real-time insurance verification and eligibility solutions. Automate workflows, reduce claim denials, and improve conversion rates with accurate, fast, and reliable tools. Book a demo today to transform your patient onboarding process.
Future Planet Capital VC Fund · London, England, United Kingdom · 4 investments in the past 12 months
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Funding Round, Convertible Note
  • United Kingdom, United States, Canada
Portfolio highlights
  • SugaROx — Discover SugaROx, pioneers in biostimulant technology. Boosting crop resilience, and yield with their science-backed agricultural solutions.
  • Ikarovec — Ikarovec is developing novel gene therapies to treat major ophthalmic indications.
  • Inicio AI — A specialist Income & Expenditure trained virtual agent delivering improved CX and robust results
Scottish Investment Bank VC Fund · Glasgow, Glasgow City, United Kingdom
Speak with our Entrepreneurship and Investment teams, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more
Investment focus
  • Software, Biotechnology, Health Care
  • Funding Round, Seed, Series A
  • United Kingdom, United States, France
Portfolio highlights
  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
Epidarex Capital VC Fund · Bethesda, Maryland, United States
Epidarex Capital invests in early-stage, high growth life science and health technology companies in under-ventured markets. Its international team is led by Sinclair Dunlop, Kyp Sirinakis and Liz Roper. With offices in the United States and United Kingdom Epidarex Capital’s investors represent a cross-section of leading universities, internationalcorporations, development agencies and financial institutions. Epidarex was created to meet the need for more sector-specific financial backing for young companies, including spin-outs from leading research universities.
Show more
Investment focus
  • Biotechnology, Therapeutics, Health Care
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • Theolytics — Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing aninternal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development.
  • Ryme Medical — Ryme Medical is a device company developing a novel catheter-based treatment for COPD
  • Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.
APEX Ventures VC Fund · Vienna, Wien, Austria · 4 investments in the past 12 months
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Software
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
  • Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
  • HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
APEX Ventures VC Fund · Vienna, Wien, Austria · 2 investments in the past 12 months
APEX Ventures is a deep-tech and medical-focused venture capital firm.
Show more
Investment focus
  • Artificial Intelligence, Health Care, Software
  • Seed, Series A, Pre-Seed
  • Germany, United Kingdom, Austria
Portfolio highlights
  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
Deepbridge Capital VC Fund · Chester, Cheshire, United Kingdom · 3 investments in the past 12 months
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Seed, Funding Round, Series A
  • United Kingdom, Australia, Singapore
Portfolio highlights
  • AI-Sight — AI-Sight is a startup that is developing an AI diabetic retinal screening system to deliver WHO-recommended diabetic eye screening services.
  • upLYFT — upLYFT is working on the next generation of smart wearables to help with musculoskeletal issues related to aging. Also working with pro athletes to help sporting individuals train harder and break records.
  • Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Verve Ventures VC Fund · Zug, Zug, Switzerland · 11 investments in the past 12 months
Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Series A, Seed, Series B
  • Switzerland, France, Germany
Portfolio highlights
  • Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
  • Poppins — Mila merges music, technology, and neuroscience to reshape therapy into a musical experience. We create musical games for children based on neurologic music therapy methods. These games are designed to address learning dissabilities like dyslexia, providing a digital treatment at home and helping identify these conditions. Behind these games, weleverage data science and new technologies to interpret learning, language, and motor performance into a cognitive score. Our goal is to improve the process for patients receiving treatment and to reaching the vast undiagnosed majority.
  • EarlySight — EarlySight start-up company is founded in order to accelerate the development and to bring the technology to clinics.
11.2 Capital VC Fund · San Francisco, California, United States
In physics, 11.2 km/s is the escape velocity from Earth's gravity. They focus on emerging technologies such as AI, cybersecurity, robotics, quantum, new space, computational therapeutics, synthetic biology. ​They believe great people are leading indicators of a company's success. 11.2 Capital’s technical background, operationalexperience, and a strong network of amazing advisors and international partners particularly in Asia deliver a unique set of resources to entrepreneurs. While they are happy to help companies across the full range of early-stage company questions, areas where they concentrate include technical recruiting, partnerships (OEM and distribution partnerships for smart hardware companies, data partnerships for data-driven healthcare companies), customer introductions (CISO introductions for security companies, provider introductions for healthcare companies), and follow-on financings.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Series A, Series B
  • United States, Canada, United Kingdom
Portfolio highlights
  • Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
  • Mantle — Mantle is an engineering and manufacturing company that has developed metal 3D printing technology to produce high-resolution parts that meet the critical needs of applications from automotive and aerospace to consumer product design and prototyping.
  • Coalesce Automation — Coalesce is the only data transformation tool built for scale. Evolve your transformations and empower your entire data team.
Angels 5K VC Fund · Winchester, Hampshire, United Kingdom
Southern Angel Investors Club, combining Surrey investors Club & Angels 5K, are entrepreneurs who understand what new businesses need.
Show more
Investment focus
  • Biotechnology, Software, Medical
  • Seed, Funding Round, Angel
  • United Kingdom
Portfolio highlights
  • Celixir — Celixir is a developer of regenerative medicines created to change the lives of patients in need. The company's medicines consists of iMP cells, platelet lysate and PML cells to treat patients with ischaemic heart disease, injured tendons near the surface of the skin and mild to moderate heart failure respectively, enabling medical researchersto discover breakthrough medicines that aim to change the standard of medical care for patients.
  • Novastone Media — Novastone enables instant chat across mobile and web to move customer conversations from email. Novastone’s white label chat solutions, built by financial industry experts, deliver on all these requirements, seamlessly moving organisations’ most valuable relationships from the inbox into a chat conversation.
  • Geektastic — Geektastic guarantees hiring teams only meet high calibre candidates. Our technical code challenges quickly identify the most talented software engineers.
Octopus Ventures VC Fund · London, England, United Kingdom · 23 investments in the past 12 months
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series A, Seed, Series B
  • United Kingdom, United States, Germany
Portfolio highlights
  • CRED — Compare millions of commercial data points and uncover unique and personalised opportunities for your brand.
  • Healsgood Ai LTD — Discover how HealsGood is revolutionising healthcare with AI-powered workforce solutions. Explore our expertise in clinical insourcing, staff bank management, and secure data-driven technology.
  • Perci Health — Connecting cancer patients with expert practitioners. On-demand, affordable appointments. Get personalised support and a tailored care plan today.
Techstart Ventures VC Fund · Belfast, Belfast, United Kingdom · 6 investments in the past 12 months
Techstart Ventures is a first-cheque investor for extraordinary founders pursuing uncapped global opportunities.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Pre-Seed, Funding Round
  • United Kingdom, Ireland, United States
Portfolio highlights
  • RETìníZE — RETìníZE is an AR, VR, multi-screen installations, and software development.
  • Cloudsmith — Cloudsmith is the only universal, cloud-native solution for software artifact management and software supply chain security. Start your free trial today.
  • Liquid Acquire — Liquid Acquire provides AI solutions for mergers and acquisitions.
AlbionVC VC Fund · London, England, United Kingdom · 13 investments in the past 12 months
AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Series A, Funding Round, Seed
  • United Kingdom, United States, France
Portfolio highlights
  • Kohort — How many users will your mobile game acquire, and how much more will they pour into your virtual economy? Try Ramp to find out.
  • OpenTrade — OpenTrade providers web3 treasurers, institutions, and accredited investors access to on-chain structured financial products backed by investment grade RWAs.
  • Latent Technology — Latent Technology builds the next-generation animation technology for virtual worlds.
Cambridge Innovation Capital VC Fund · Cambridge, Cambridgeshire, United Kingdom · 6 investments in the past 12 months
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United Kingdom, United States, Ireland
Portfolio highlights
  • Sortera Bio — Sortera Bio operates as a biotechnology company. Sortera is committed to providing revolutionary solutions in biologics discovery.
  • Salience Labs — Salience Labs is building a hybrid photonic-electronic chip for AI. We have designed a massively parallel, ultra-high-throughput Photonic Tensor Processing Unit. Photonics allows data to be modulated at up to 100 GHZ, and allows for high levels of parallelization using multiplexing. We integrate this photonic unit into a SoC architecture designedto exploit its high throughput for AI inference. Salience Labs technology is based on decades of research collaboration between Oxford University and the University of Münster, Germany.
  • TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
IP Group VC Fund · London, England, United Kingdom · 6 investments in the past 12 months
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
  • Health Care, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Australia
Portfolio highlights
  • Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Playfair Capital VC Fund · London, England, United Kingdom · 4 investments in the past 12 months
Playfair is a generalist VC fund with a contrarian approach to pre-seed technology investing. Based in London, Playfair invests across the UK and Europe with an intentionally high conviction, low volume approach: making 6-8 investments a year and preserving time, capital and resource to help companies post-investment. Playfair has backed 70+companies across two funds including Thought Machine, Andela, Mapillary, Recycleye and Orca AI.
Show more
Investment focus
  • Software, Artificial Intelligence, E-Commerce
  • Seed, Series A, Funding Round
  • United Kingdom, United States, France
Portfolio highlights
  • Warden AI — Warden AI is an AI assurance platform for validating fair, compliant, and trustworthy AI systems. Schedule a demo to learn more!
  • Those Beyond — Those Beyond develops a social gaming platform that supports interactive fan experiences within fictional universes. The platform uses its proprietary Arise Engine to enable browser-based adventures, role-playing, and puzzle-solving activities involving mass community participation. Projects include collaborations with entertainment franchises suchas "The Walking Dead," allowing fans to engage with story-driven challenges and community events. The platform includes customizable social spaces designed to reflect the themes and aesthetics of the associated intellectual properties.
  • Astral Systems — Our compact multi-state fusion reactors offer high particle flux and exceptional lifetime performance, unlocking a wide variety of critical medical, industrial, and research applications today.
O2h Ventures VC Fund
Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Seed, Series A, Pre-Seed
  • United Kingdom, Hungary
Portfolio highlights
  • Healx — At Healx we use AI drug discovery to develop new treatments for rare diseases. We bring treatments from prediction to patient.
  • Atelerix — Discover Atelerix's hypothermic hydrogels for eco-friendly, reliable cell preservation and ambient temperature shipping. Ensure fresh, viable cell samples today.
  • ViaNautis — Precision Solutions
Mercia Fund Managers VC Fund · Henley In Arden, Warwickshire, United Kingdom
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Series A
  • United Kingdom, United States, Hungary
Portfolio highlights
  • Administrate — Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program.
  • Warwick Acoustics — Warwick Acoustics believe in creating products that are designed from the ground up in order to deliver the best personal audio listening experience available to customers.
  • Melius Cyber — Melius Cyber continuously monitors an organization's IT network, testing security and protecting it from the latest threats.
Oxford Capital VC Fund · Oxford, Oxfordshire, United Kingdom · 6 investments in the past 12 months
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Funding Round, Seed, Series A
  • United Kingdom, United States, France
Portfolio highlights
  • Egregious — Egregious is an advanced research & intelligence lab established to defend humans from AI and provides narrative intelligence solutions across the public and private sectors to protect organisations and online users from malign influence using AI-driven data acquisition, insights, and engagement.
  • Arcube — We make sure all travellers, frequent and infrequent, make the most of travel loyalty programs, using our data-driven approach, airlines can understand their customers and provide hyper-personalised offerings to boost value and retention.Arcube uses a data-driven approach to make the most of airline loyalty programs for both frequent andinfrequent flyers. Our software allows airlines to understand their customers and provide hyper-personalised offerings to boost value and retention at no extra cost to the airline.
  • FinCrime Dynamics — Our mission is to help make the world’s financial system safer through rapid deployment of effective AI for financial crime analytics, enabled by enriched synthetic data that captures the dynamics of fraud and money laundering and loads them into tailor-made scenarios that explore diverse threats that financial organisations are exposed to.Thisgoal has taken us to the forefront of Synthetic Data and Fincrime Analytics, and we are proud to have in our team people that have helped shape the state-of-the-art of these fields.Keywords: Finacial services, AML, Synthetic Data, Fintech, Machine learning, Big data, Simulation, Fraud Analytics, Compliance
Formic Ventures VC Fund · San Francisco, California, United States
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups focused on human longevity as well as technology startups and companies that make human lives more meaningful.
Show more
Investment focus
  • Biotechnology, Health Care, Biopharma
  • Seed, Series A, Funding Round
  • United States, United Kingdom, Hong Kong
Portfolio highlights
  • SonoThera — SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound. Its mission is to develop genetic medicines that treat the root cause of human disease. SonoThera is expanding the possibilities of disease treatment with ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments. Itaims to improve the lives and health of millions of people.
  • cheMastery — Echo handles repetitive tasks with accuracy and precision, allowing your chemists to tackle high-value challenges.
  • Biogenesis — Clinical research platform tailored towards industry sponsors, clinical research sites & patients
Dementia Discovery Fund VC Fund · London, England, United Kingdom · 4 investments in the past 12 months
SV Health Investors is a specialist healthcare fund manager, investing across multiple stages and sectors. Our goal is to transform healthcare one investment at a time.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Seed, Funding Round
  • United States, United Kingdom, Israel
Portfolio highlights
  • Therini Bio — Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.
  • Montara Therapeutics — Montara Therapeutics is a precision-medicine neuroscience biotech startup improving safety and efficacy of therapies for people with neurological diseases
  • TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
SR One VC Fund · Cambridge, Massachusetts, United States · 7 investments in the past 12 months
SR One Capital Management is a leading trans-Atlantic biotech venture capital firm that partners with top entrepreneurs, scientists and investment partners to seek to build elite biotechnology companies. Our mission is to translate ground-breaking technologies into next generation medicines to benef
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, United Kingdom, Canada
Portfolio highlights
  • Fore Biotherapeutics — We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
  • Draig Therapeutics — Draig Therapeutics is a clinical-stage biopharmaceutical startup dedicated to creating next-generation treatments for serious neuropsychiatric illnesses.
  • ORIC Pharmaceuticals — ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s lead product candidate,ORIC-101, is a potent and selective small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeuticsacross a variety of solid tumors. ORIC’s second product candidate, ORIC-533, is an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens. Beyond these two product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC’s scientific founders, Charles Sawyers, MD, and Scott Lowe, PhD, have long records of discovering novel targets in cancer that have led to innovative treatments.
Bioeconomy Capital VC Fund · Seattle, Washington, United States
Bioeconomy Capital invests in early-stage companies with the goal of accelerating the biotechnology revolution. Based on its startup operational expertise, product development experience, and globally recognized strategic analysis, it has developed a blueprint for building and deploying technological capabilities that will become a criticalinfrastructure of the 21st-century economy.The company's proprietary blueprint is the distillation of the fund managers'​ five decades of combined experience in synthetic biology and other engineering fields and cannot be readily duplicated. Prior investments include Zymergen, Riffyn, Synthace, RoosterBio, Arzeda, Bellwether Bio, EdenWorks, and Lumen Biosciences.
Show more
Investment focus
  • Biotechnology, Life Science, Pharmaceutical
  • Series A, Series B, Seed
  • United States, United Kingdom
Portfolio highlights
  • MicroByre — MicroByre is a platform for bacterial domestication. Their automated characterization pipeline gathers the oft-overlooked data that highlights unleveraged bacteria that meet functional industrial criteria. That is, they rapidly find the bacteria with naturally unfussy eating habits and evolution-honed metabolisms that have the potential to convertunrefined biomasses into commodity chemicals at vastly improved efficiencies compared to extant fermentation processes. They select from these functionally de-risked bacteria those which can be directly genetically modified to improve their cost profiles — even if they have never been engineered before. The data from our unique characterization pipeline informs the minimally precise genetic modifications necessary to increase pliability and yield, eliminate nutritional additives, maximize feedstock utilization, and improve contamination tolerance & phage resistance. MicroByre gives biomass conversion a truly competitive edge against petrochemical synthesis.MicroByre’s platform bridges the gap between the promising and the profitable in synthetic biology and bioengineering. A unique combination of resources and skills makes MicroByre a valuable potential partner for companies of all sizes and industries. They collaborate to define project scope to match a mutually agreeable business model, which could be a fee for service, license agreement, or joint development agreement.
  • Tandem PV — Discover the future of sustainable energy with Tandem PV, a leader in perovskite solar technology and innovative solar energy solutions.
  • Parse Biosciences — Parse Biosciences is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Learn more about how you can use the most scalable single cell platform on the market without the need for custom instrumentation.
Fifty Years VC Fund · San Francisco, California, United States · 2 investments in the past 12 months
WE BACK HEROES using technology to solve the world's biggest problems
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Seed, Series A, Series B
  • United States, Germany, Canada
Portfolio highlights
  • Deepcell — Deepcell uses AI to isolate and capture cells based on morphological features for multiple research and translational applications.
  • Gridware — Using remote telemetry and edge AI, Gridware wildfire prevention technology powers a grid that is smarter and more reliable than ever before.
  • Aalo Atomics — Creating abundant and dependable clean energy to power humanity for generations.
Molten Ventures VC Fund · London, England, United Kingdom · 8 investments in the past 12 months
Molten Ventures is a venture capital company. They invest in software, telecoms, electronics, the internet, MedTech, and cleantech services. They support visionary entrepreneurs who will invent the future.
Show more
Investment focus
  • Software, Information Technology, Financial Services
  • Series A, Series B, Funding Round
  • United Kingdom, United States, Germany
Portfolio highlights
  • PocDoc — PocDoc is a pioneer in the field of smartphone-based fast disease testing.
  • FintechOS — FintechOS extends your core, letting you innovate banking and insurance products, digital journeys, and back-office workflows without the cost or risk.
  • SatVu — SatVu captures high resolution thermal data from space for a safer and more sustainable Earth.
Antler VC Fund · Singapore, Central Region, Singapore · 118 investments in the past 12 months
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Pre-Seed, Seed, Series A
  • Singapore, United Kingdom, Australia
Portfolio highlights
  • FitFlo — FitFlo brings to life the connected gym experience for Operators, Trainers and Members.
  • Mole — Mole is a digital business card and mobile website software. Connect with your clients, promote your business online and much more. Comes with free customised NFC business card.
  • Optacloud — Fostering a global AI powered ecosystem to achieve 100% cloud efficacy-> effortlessly, economically and eco-consciously. Dev tools stack for automating the entire development lifecycle of cloud apps across- Build, Deploy & Optimize.
Praetura Ventures VC Fund · Manchester, Manchester, United Kingdom · 10 investments in the past 12 months
Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Funding Round, Seed, Series A
  • United Kingdom
Portfolio highlights
  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Cytix — Cytix is a vulnerability management software platform and cluster of dedicated pentesters to help you identify & resolve Vulnerabilities. Reach us & get a free trial of tool.
  • Ocula Technologies — Harness the power of advanced analytics with our sustainable growth platform enabling brands and retailers to outperform competitors.
Maki.vc VC Fund · Helsinki, Southern Finland, Finland · 6 investments in the past 12 months
Maki.vc is an early-stage venture capital firm partnering with deep tech & brand-driven startups obsessed with challenging category norms.
Show more
Investment focus
  • Software, E-Commerce, Information Technology
  • Seed, Series A, Funding Round
  • Finland, Germany, United Kingdom
Portfolio highlights
  • Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
  • TrackSights — TrackSights combines top-tier data, automated workflows, and actionable insights for the automotive industry. Streamline decisions, calculate values, and manage fleets effortlessly with a modern, easy-to-use interface. Book a demo today!
  • Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Amadeus Capital Partners VC Fund · Cambridge, Cambridgeshire, United Kingdom · 9 investments in the past 12 months
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Series B, Seed, Series A
  • United Kingdom, United States, Spain
Portfolio highlights
  • PhoreMost — PhoreMost is a new-model drug discovery company based in Cambridge, UK: Using its core expertise to open up new ‘druggable’ target space and working with a global network of co-invested academic and industrial collaboration partners, we aim to bring a wide array of novel ‘targeted’ therapies more efficiently to market and pass these cost savingsonto patients.
  • Riverlane — Riverlane's mission is to make quantum computing useful far sooner than previously imaginable, starting an era of human progress as significant as the industrial and digital revolutions.
  • qomodo — Intelligent IOT Embedded Security. We protect commercial or industrial IOT devices from the threats of the internet. Driven by leading intelligence and machine learning, our anomaly detection allows us to protect even the simplest IOT devices.
Creator Fund VC Fund · London, England, United Kingdom · 8 investments in the past 12 months
We invest in founders building business on the frontier of what is possible. Creator Fund believes...
Show more
Investment focus
  • Machine Learning, Software, Artificial Intelligence
  • Pre-Seed, Seed, Series A
  • United Kingdom, Canada, Israel
Portfolio highlights
  • Fairgen — Data-centric approach to debiasing machine learning models and artificial intelligence algorithms.
  • Malted AI — Malted AI is a developer of a low-code platform enables enterprises to build and deploy large language models-enabled applications at scale, using distillation to inject domain-specific knowledge into smaller, focused models, trained on proprietary data in a secure environment.
  • Helical — Helical is an intermediary platform that offers bioinformaticians free access to the technologies from AI and biological computation.
GV VC Fund · Mountain View, California, United States · 47 investments in the past 12 months
GV supports innovative founders moving the world forward.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Series A, Series B, Seed
  • United States, United Kingdom, Switzerland
Portfolio highlights
  • Intent Inc — GroupUltra is a platform that allows users to program their groups and design their communities.
  • Phoebe — Phoebe is an agentic search tool for tech stack data. It helps engineering teams to troubleshoot many sorts of problems much faster, from minor bugs to major incidents. Phoebe can also initiate searches proactively to help anticipate and triage new issues.
  • Blue Water Autonomy — Blue Water Autonomy develops fully autonomous, unmanned ships designed from the keel up for long-endurance missions. Its vessels, about 100 feet and 100 tons, are purpose-built for open-ocean operations with modular payloads for logistics, surveillance, or munitions. The ships integrate hardware, software, and AI systems to operate independentlyover long durations. They are engineered for mass producibility, using medium-sized shipyards to keep production simpler and more cost-effective than traditional crewed ships. While initially focused on defense applications, the company also targets future use in commercial sectors such as cargo shipping, offshore energy, and other demanding maritime operations.
Maven Capital Partners VC Fund · Glasgow, Glasgow City, United Kingdom · 17 investments in the past 12 months
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Funding Round, Seed, Series A
  • United Kingdom, United States, Germany
Portfolio highlights
  • Q5D Technology — Additive manufacturing with conductors. Eliminate traditional wiring, saving space and weight. Unique 5-axis robots add power and data functions to products. Simplify supply chains and manufacturing. Transform productivity with our hardware, software, and support.
  • CWCS Managed Hosting — Let CWCS handle your hosting, full management, 24/7 expert support, seamless migrations, and UK-based performance you can trust.
  • Laverock Therapeutics — Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
Hoxton Ventures VC Fund · London, England, United Kingdom · 9 investments in the past 12 months
Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
Show more
Investment focus
  • Artificial Intelligence, Information Technology, Software
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Canada
Portfolio highlights
  • Cogna — Cogna offers an AI-powered SaaS platform that streamlines the integration of data across several business domains.
  • CuspAI — CuspAI is a revolutionary AI startup that is developing a platform for next-generation materials to address global sustainability and renewable energy concerns. CuspAI uses cutting-edge generative AI, deep learning, and molecular simulation to accelerate the material design process. Their platform works similarly to a search engine for materials,allowing users to request certain properties for new materials on demand.
  • Malted AI — Malted AI is a developer of a low-code platform enables enterprises to build and deploy large language models-enabled applications at scale, using distillation to inject domain-specific knowledge into smaller, focused models, trained on proprietary data in a secure environment.
Acequia Capital (AceCap) VC Fund · Seattle, Washington, United States · 9 investments in the past 12 months
We are a leading early-stage investment platform. We are at the center of a global ecosystem that attracts and fuels the technical founders and product teams building the next wave of global businesses.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Seed, Series A, Pre-Seed
  • United States, United Kingdom, Germany
Portfolio highlights
  • Arago — Arago is an AI and computer hardware company developing an energy-efficient AI chip powered by light, and its associated software.
  • Tracelight — Tracelight is an AI-powered Excel add-in that enhances financial modeling by enabling users to generate formulas from natural language, check for errors, and interact with models using plain English. It helps financial professionals save time, reduce errors, and work more efficiently while maintaining security and data privacy.
  • Hyperdrives — Discover Hyperdrives, a deep-tech engineering company providing electric drive systems designed to set a new benchmark for performance-to-cost.
Investors by industry
Investors by country
VC (Venture Capital) Funds in United Kingdom by industry